EyePoint Pharmaceuticals has completed enrollment in its Phase 3 LUCIA trial of DURAVYU (vorolanib intravitreal insert) for wet age-related...

Pharmazz has initiated its pivotal Phase 3 RESPECT-ETB trial evaluating sovateltide, a first-in-class endothelin-B receptor agonist, in acute cerebral...

Fulcrum Therapeutics reported positive 12-week data from the 12mg dose cohort of its Phase 1b PIONEER trial of pociredir...

Emergent BioSolutions announced the publication of a review article on the use of its investigational antiviral drug, brincidofovir, for...

NetraMark Holdings Inc., an AI company specializing in clinical trials, and AlgoTherapeutix SAS (AlgoTx), a biotech company developing therapies...

Radiopharm Theranostics has received FDA Investigational New Drug (IND) application clearance for Betabart (RV-01), a Lu177-B7H3 monoclonal antibody targeting...

Entera Bio received positive feedback from the FDA regarding its New Drug Application (NDA) for EB613, an oral treatment...

Alterity Therapeutics announced positive topline data from its open-label Phase 2 clinical trial (ATH434-202) of ATH434 in individuals with...

In this interview with Bobby Reddy, Chief Medical Officer at ImmunityBio, we explore the company’s groundbreaking work in cancer...

ReShape Lifesciences is hosting its first Lap-Band Surgeon Summit from August 1st to 3rd, 2025, in Nashville, Tennessee. The...